CymaBay Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on CymaBay Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date CymaBay Therapeutics Inc Strategy Report
- Understand CymaBay Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on CymaBay Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| CA3203235C | Grant | Treatment of cholangiopathies with seladelpar | A61K31/192; A61P1/16 | April 09, 2024 |
| EP4225291B1 | Grant | Behandlung von cholangitis mit seladelpar | A61K31/192; A61P1/16 | March 13, 2024 |
| CA3024155C | Grant | Low dose oral formulations of seladelpar and use thereof in the treatment of primary biliary cholangitis. | A61K31/192; A61K9/0053; A61K9/20; A61K9/48; A61P1/16 | October 10, 2023 |
| IL304873A | Application | Treatment of cholangiopathies with seladelpar | A61K31/192; A61P1/16 | October 01, 2023 |
| CN116761597A | Application | Method for treating biliary duct disease by using saillard pag | A61K31/192; A61P1/16 | September 15, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer